• By ICR Secretariat
  • Posted Thursday, August 18, 2022

Amgen’s low tax rates draw attention of top Democratic senator

https://www.biopharmadive.com/news/wyden-amgen-tax-investigation-enbrel-puerto-rico/629580/

Last year, Amgen paid taxes equivalent to just over 12% of its nearly $7 billion in pre-tax profits, well below the U.S. corporate rate of 21%. The year before, the California-based biotechnology company paid even less, 10.7%, and for all but one of the past 10 years its effective tax rate has been below 16%.